导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -2.15% | 614/1050 |
| 近一周 | -3.53% | 898/1104 |
| 近一月 | -0.24% | 98/1102 |
| 近一季 | 1.65% | 184/1092 |
| 近半年 | -9.76% | 756/1070 |
| 近一年 | -0.56% | 598/1018 |
| 近两年 | 29.77% | 679/926 |
| 近三年 | 14.27% | 556/834 |
| 成立以来 | 148.23% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
1.59% 373/1070 |
-15.62% 1027/1101 |
- - |
- - |
| 2025 | 13.94% 775/1065 |
1.80% 659/1014 |
-0.80% 745/1038 |
13.19% 780/1050 |
-0.32% 475/1065 |
| 2024 | 12.04% 240/1011 |
5.86% 89/960 |
6.78% 57/983 |
6.99% 820/991 |
-7.35% 794/1011 |
| 2023 | -7.75% 272/952 |
3.26% 423/880 |
-4.30% 479/895 |
1.49% 48/915 |
-8.02% 759/952 |
| 2022 | -8.68% 72/867 |
-11.85% 141/773 |
5.52% 490/806 |
-6.74% 103/845 |
5.27% 192/867 |
| 2021 | 2.47% 330/740 |
5.57% 45/580 |
2.33% 504/659 |
-5.91% 385/704 |
0.81% 402/740 |
| 2020 | 71.48% 139/554 |
-9.14% 372/419 |
14.56% 361/466 |
27.79% 12/517 |
28.91% 41/554 |
| 2019 | 42.40% 201/410 |
17.91% 960/1146 |
2.61% 135/1228 |
3.31% 240/390 |
13.92% 71/410 |
| 2018 | -17.59% 45/349 |
- - |
-1.00% 99/990 |
-2.19% 317/1000 |
-10.99% 384/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.53% |
| 招商医药健康产业股票 | 2.5730 | 49.25% |
| 广发医药精选股票C | 1.2923 | 40.43% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 嘉实医疗保健股票 | 2.5780 | 38.47% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 中欧医疗创新股票A | 1.6444 | 34.01% |
| 中欧医疗创新股票C | 1.5481 | 33.74% |
| 嘉实价值精选股票 VS. 东吴新产业精选股票A(580008) |